Last reviewed · How we verify
NCT05672160: TAVI_Sarx
Overal Survival After TAVI According to Sarcopenia
trial testing CT evaluated sarcopenia in Sarcopenia in 930 participants. Completed in 2 January 2023.
1 January 2023
Quick facts
| Lead sponsor | Nemocnice AGEL Trinec-Podlesi a.s. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 930 |
| Start date | 1 January 2022 |
| Primary completion | 1 January 2023 |
| Estimated completion | 2 January 2023 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- CT evaluated sarcopenia
Conditions studied
- Sarcopenia — all drugs for Sarcopenia →
- Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →
Sponsor
Nemocnice AGEL Trinec-Podlesi a.s.
Who can join
Eligibility, any sex, with Sarcopenia or Aortic Valve Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to compare the overal survival after transcatheter aortic valve implantation (TAVI) according to sarcopenia status evaluated from preprocedural CT scans. The main question it aims to answer is: • Is CT evaluated sarcopenia an independent predictor of overal survival after TAVI?
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Sarcopenia and adipose tissue evaluation by artificial intelligence predicts the overall survival after TAVI.
Pekař M, Jiravský O, Novák J, Branny P, et al · · 2024 · cited 11× · PMID 38632317 · DOI 10.1038/s41598-024-59134-z
Verify or expand the search:
- PubMed search for NCT05672160
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcopenia
Currently open trials in the same condition.
- NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
Other Nemocnice AGEL Trinec-Podlesi a.s. trials
Trials by the same sponsor.
- NCT07433309 — CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease · not yet recruiting
- NCT06539416 — Mixed Reality in MitraClip Implantation: Preliminary Case Series · recruiting
- NCT05148923 — Comparison of Two DCCV Algorithms - Rational Versus Maximum Fixed Energy · NA · completed
- NCT06707506 — Atrial Fibrillation Risk After Miniinvasive Mitral Valve Repair · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05672160 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nemocnice AGEL Trinec-Podlesi a.s.
- Last refreshed: 5 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05672160.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing